Mira Pharmaceuticals Files 8-K
Ticker: MIRA · Form: 8-K · Filed: Dec 10, 2024 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Dec 10, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Other Events
TL;DR
Mira Pharma filed an 8-K, but details on the 'other event' are scarce.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on December 10, 2024, to report other events. The company, formerly known as Mira1a Therapeutics, Inc. until January 12, 2022, is incorporated in Florida and headquartered in Miami. The filing does not disclose specific details about the 'other events' but serves as a notification to the SEC.
Why It Matters
This 8-K filing indicates that Mira Pharmaceuticals has reported an event to the SEC, which could be material information for investors. However, the specific nature of the event is not detailed in the provided text.
Risk Assessment
Risk Level: low — The filing is a standard procedural report without specific financial or operational disclosures that would immediately indicate high risk.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former Name
- December 10, 2024 (date) — Date of Report
- Florida (location) — State of Incorporation
- Miami (location) — Principal Executive Offices City
FAQ
What is the exact nature of the 'Other Events' reported in this 8-K filing?
The provided text of the 8-K filing does not specify the exact nature of the 'Other Events' being reported.
When was Mira Pharmaceuticals, Inc. formerly known as Mira1a Therapeutics, Inc.?
Mira Pharmaceuticals, Inc. was formerly known as Mira1a Therapeutics, Inc. as of January 12, 2022.
Where are Mira Pharmaceuticals, Inc.'s principal executive offices located?
Mira Pharmaceuticals, Inc.'s principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
What is the SEC file number for Mira Pharmaceuticals, Inc.?
The SEC file number for Mira Pharmaceuticals, Inc. is 001-41765.
What is the IRS Employer Identification Number for Mira Pharmaceuticals, Inc.?
The IRS Employer Identification Number for Mira Pharmaceuticals, Inc. is 85-3354547.
Filing Stats: 850 words · 3 min read · ~3 pages · Grade level 14.7 · Accepted 2024-12-10 08:45:35
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MIRA The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 39KB
- 0001493152-24-049377.txt ( ) — 214KB
- mira-20241210.xsd (EX-101.SCH) — 3KB
- mira-20241210_lab.xml (EX-101.LAB) — 33KB
- mira-20241210_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIRA PHARMACUTICALS, INC. Dated: December 10, 2024 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer